|
||
| |||||||
|
MIP wins pyrethroid residue detection contract with US EPA
New contract with US administration
follows work for CDC in Atlanta
Lund, Sweden, July 19, 2005
- MIP Technologies AB, a developer and producer of molecularly imprinted
polymers (MIP) for separations and drug discovery, announced today that it had
entered into a contract with the United States Environmental Protection Agency
for the development of MIP based solid-phase extraction materials for the
determination of pyrethroid pesticide residues in composite dietary samples.
The pyrethroid pesticides, which exhibit toxicity
towards aquatic invertebrates and fish, will be monitored by the EPA in
exposure studies where detection limits in the sub-part per billion (ppb)
range are required. Existing methods typically have detection limits ranging
from 5-50 ppb. The increase in detection limit requirements by environmental
agencies in both the US and Europe demands clean-up procedures that are more
selective for the target analytes and which reduce the amount of irrelevant
chemical species that may interfere with subsequent analysis.
"Molecular imprinting is now recognized as a
powerful method for the development of selective separation materials and we
are hopeful it may provide the solution we need for the analysis of pyrethroid
residues in complex matrices," said Dr Jeffrey Morgan of the EPA National
Exposure Research Laboratory in Cincinnati.
"We are extremely pleased to be working with USEPA,
one of the worlds largest and most prestigious environmental agencies," said
Dr Anthony Rees, CEO at MIP Technologies. "This collaboration follows on from
our recent interactions with another well known US institution, The Centers
for Disease Control and Prevention (CDC) to whom we now supply an analytical
solution in a different area. We firmly believe that MIPs will provide the
selective separation solutions of the future and look forward to further
involvement with the important US market."
About MIP Technologies:
www.miptechnologies.se
MIP Technologies AB is a world leading company in
the development and production of molecularly imprinted polymers (MIPs). MIPs
are stable polymer materials in which artificial receptor sites have been
created for use in separations and drug discovery. The company is dedicated to
the development, production and marketing of innovative, MIP-based products,
directly and through collaborations. MIPs can be applied as selective sorbents
in analytical sample pre-treatment, chemical sensing, dedicated separations or
as screening elements in drug discovery. The company has developed this
technology platform enabling a rapid and economic development of custom-made
phases with superior properties. MIP Technologies is headquartered in Lund,
Sweden.
For further information, please contact: |
|
| ||||||||